View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Lazertinib 240 / Amivantamab 2240, Non-Small Cell Lung Cancer, Cycle 1
Protocol-ID: 2904 V1.0 (Mini), LAZE240/AMIV2240, NSCLC, C1Indication(s)
- Lung Carcinoma, Non-Small Cell; ICD-10 C34.-
EGFR exon 19 deletion mutation ● EGFR exon 21 Leu858Arg mutation
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. |
Valid since: 19.05.2025